Clominorex
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(RS)-5-(4-chlorophenyl)-4,5-dihydro-1,3-oxazol-2-amine | |
| Identifiers | |
| CAS Number |
3876-10-6 |
| ATC code | none |
| PubChem | CID 19752 |
| ChemSpider |
18605 |
| UNII |
O1R2462WA0 |
| KEGG |
D03552 |
| ChEMBL | CHEMBL2104179 |
| Chemical data | |
| Formula | C9H9ClN2O |
| Molar mass | 196.63 g/mol |
| Chirality | Racemic mixture |
| |
| |
| (verify) | |
Clominorex is a centrally acting sympathomimetic which is related to other drugs such as aminorex and pemoline. It was developed as an appetite suppressant by McNeil Laboratories in the 1950s.[1]
See also
References
- ↑ US Patent 3278382 - 2-amino-5-aryloxazoline compositions and methods of using same
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
